Content area

|
|

Behandling af synstruende diabetisk retinopati

Forfatter(e)
Jakob Grauslund1, 2 1) Øjenafdeling E, Odense Universitetshospital 2) Forskningsenheden for Oftalmologi, Klinisk Institut, Syddansk Universitet Ugeskr Læger 2018;180:V11170870
Reference: 
Ugeskr Læger 2018;180:V11170870
Sidetal: 
2-5
Treatment of sight-threatening diabetic retinopathy
In diabetic retinopathy, treatment is indicated for sight-threatening complications like proliferative diabetic retinopathy (PDR) and diabetic macular oedema (DME). For decades, treatment has been with panretinal laser for PDR and focal/grid laser for DME. In recent years, intravitreal therapy with vascular endothelial growth factor (VEGF) inhibition or steroids has replaced laser treatment in centre-involving DME. Intravitreal VEGF-inhibition has also demonstrated effectiveness in PDR, but long-term studies are needed to address the concern of a potential continuous treatment burden.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Eskild Boeskov | 23/01
6 kommentarer
af Pal Bela Szecsi | 20/01
2 kommentarer
af Peter Søndergaard | 18/01
3 kommentarer
af Mads Henrik Koch Hansen | 16/01
2 kommentarer
af Lars Guttorm | 14/01
5 kommentarer
af Morten Ellemose Gulev | 14/01
4 kommentarer
af Henning Damgaard Laugesen | 14/01
1 Kommentar